Nanobiotix
NBTX
5 hedge funds and large institutions have $17.7M invested in Nanobiotix in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
43% more capital invested
Capital invested by funds: $12.4M → $17.7M (+$5.36M)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.1% less ownership
Funds ownership: 9.93% → 9.83% (-0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.55K |
| 2 |
JP Morgan Chase
New York
|
+$9 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $7.25M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $5.37M | – | – | – |
|
|
AG
3
Artal Group
Luxembourg
| $5.07M | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $20.3K | +$4.55K | +1,002 | +33% |
|
|
5
JP Morgan Chase
New York
| $10 | +$9 | +2 | New |
|
NBTX Hedge Fund Activity: Q2 2023 in Review
5 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q2 2023, worth a combined $17.7M — up 43% from $12.4M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NBTX positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $4.55K.
- 5 institutional investors held Nanobiotix (NBTX) as of Q2 2023, up from 4 in Q1 2023.
- Funds reported $17.7M of Nanobiotix stock for Q2 2023, up 43% quarter-over-quarter.
- 1 fund opened new Nanobiotix positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Nanobiotix buyer in Q2 2023 was UBS Group, an estimated $4.55K added.
Based on aggregated 13F filings for Q2 2023.